Clovis Oncology's cancer drug Rubraca succeeds in key study

Clovis Oncology reported that its Rubraca met primary and secondary endpoints in a new phase 3 trial

Clovis Oncology reported that its Rubraca met primary and secondary endpoints in a new phase 3 trial

Investors sentiment decreased to 1.03 in Q4 2016. It is negative, as 30 investors sold Clovis Oncology Inc shares while 48 reduced holdings.

Endurant Capital Management LP raised its position in shares of Clovis Oncology, Inc. Manufacturers Life Insur The holds 21,957 shares or 0% of its portfolio. Jpmorgan Chase And Co reported 170,388 shares. Geode Cap Management Ltd holds 290,450 shares. Clovis Oncology Inc (NASDAQ:CLVS) has risen 282.71% since June 19, 2016 and is uptrending. Citigroup reported 247,642 shares. PNC Financial Services Group Inc. now owns 2,800 shares of the biopharmaceutical company's stock worth $179,000 after buying an additional 100 shares in the last quarter. Proshare Ltd Liability invested in 0.02% or 30,597 shares. Additionally, the stock's volume is skyrocketing with almost 11 million shares already sold today. Td Asset Mngmt accumulated 17,226 shares or 0% of the stock.

EAM Investors LLC acquired a new stake in Clovis Oncology, Inc. Palo Alto Ltd Liability Corporation holds 9.64% or 3.80M shares in its portfolio. 183,693 are owned by Voloridge Inv Mgmt Limited Liability Company.

Since March 15, 2017, it had 0 insider purchases, and 3 selling transactions for $528,600 activity. The firm issued an outperform rating and a $85.00 price target on the biopharmaceutical company's stock. Endurant Capital Management Limited Partnership stated it has 0.34% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS). Therefore 79% are positive. Company stock is -21.16% away from its one year high and is moving 83.42% ahead of its one year low. They now have a $75.00 price objective on the biopharmaceutical company's stock.

05/01/2015 - Clovis Oncology, Inc. was upgraded to " by analysts at Zacks. Wells Fargo Mn holds 0% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS) for 40,543 shares. They now have a United States dollars 23 price target on the stock. The stock of Clovis Oncology Inc (NASDAQ:CLVS) has "Overweight" rating given on Thursday, January 26 by PiperJaffray. The firm has "Overweight" rating given on Friday, January 13 by Morgan Stanley.

On October 25, 2016 Chardan Capital initiated coverage on the stock with an initial rating of "Sell". WallachBeth Capital maintained Clovis Oncology Inc (NASDAQ:CLVS) rating on Monday, May 9. Ladenburg Thalmann Financial Services Inc. increased its stake in Clovis Oncology by 20.0% in the fourth quarter. The consensus recommendation by Thomson Reuters Analysts is Hold for KOPN and their mean rating for the stock is 3.00 on scale of 1-5.

Canada to increase military spending 70 percent in 10 years
With the additional money being poured in, Ottawa reports it will spend $533 billion in all on defense in the next 20 years. According to the announcement, Canada has allocated about $18.9 billion Canadian for defense in its 2016/17 budget.

A look at some of the inputs to technical analysis model shows how Clovis Oncology, Inc. current price compares to its recent moving averages. Finally, Credit Suisse Group boosted their price target on shares of Clovis Oncology from $53.00 to $70.00 and gave the stock an "outperform" rating in a research report on Thursday, February 23rd. The latest reports which are outstanding on Monday 19th of June state 3 analysts have a rating of "strong buy", 5 analysts "buy", 3 analysts "neutral", 1 analysts "sell" and 0 analysts "strong sell".

Investors wait Clovis Oncology Inc (NASDAQ:CLVS) to report on August, 14. its quarterly earnings Wall Street analysts expect $-1.37 EPS, up $0.70 or 33.82 % from last year's $-2.07 same quarter earnings.

Clovis Oncology, Inc is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other worldwide markets. The company's market cap is $3.93 billion. Equities research analysts anticipate that Clovis Oncology will post ($4.95) earnings per share for the current fiscal year.

In December, Rubraca was granted accelerated approval by the U.S. Food and Drug Administration for patients whose tumors have a BRCA mutation and whose disease has continued to develop despite multiple rounds of chemotherapy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Recommended News

  • Koepka's trip around the world leads to major title at home

    Koepka's trip around the world leads to major title at home

    It was an awesome day of Golf yesterday at Erin Hills, Wisconsin . "Obviously I need to do that more often". On the 13th hole, Koepka sank a par putt to give him the outright lead after Harmen bogeyed on the 12th.
    Coveney calls for North deal to 'involve all five parties'

    Coveney calls for North deal to 'involve all five parties'

    Mr Coveney said a deal was "do-able" but there were differences between the parties that needed to be bridged. Sinn Féin's Stormont leader Michelle O'Neill said her party was up for striking a deal.
    Suspected attacker dead in Paris after car crashes into police vehicle

    Suspected attacker dead in Paris after car crashes into police vehicle

    Police forces secure the area on the Champs Elysées next to the suspected vehicle , center, in Paris, Monday, June 19, 2017 . Gerard Collomb, France's interior minister, explained to reporters that the suspects auto contained weapons and explosives.
  • Finsbury Park suspect held for terrorism offences and attempted murder

    The appalling attack on Muslims in Finsbury Park is an attack on us all and on the culture and values of our country. People surrounded the driver and witnesses said the outraged crowd began attacking him.
    Floyd Mayweather, Conor McGregor Will Face-Off On August 26th

    Floyd Mayweather, Conor McGregor Will Face-Off On August 26th

    Incredibly, the Daily Star recently claimed that McGregor wanted a $100 million purse to take on the undefeated Mayweather. UFC president Dana White said Wednesday that there will be fines and penalties in place if such actions were to occur.
    Kovind is NDA Presidential candidate

    Kovind is NDA Presidential candidate

    However, there are signs that all the opposition parties might not share the same views when it comes to Kovind's nomination. The BJP, Ms Banerjee said, could have fielded a candidate of "stature" like Pranab Mukherjee, LK Advani or Sushma Swaraj.
  • Why People Are Upset About Gal Gadot's 'Wonder Woman' Salary

    Why People Are Upset About Gal Gadot's 'Wonder Woman' Salary

    On the surface, other superhero actors such as Chris Evans could claim to be similarly hard done (well, by Hollywood standards). As reported by The Daily Dot , Gal Gadot only earned $300,000 Dollars for her excellent performance in Wonder Woman .
    No support if Centre nominated 'Dalit' face for vote bank: Shiv Sena

    No support if Centre nominated 'Dalit' face for vote bank: Shiv Sena

    Sena spokesperson Manisha Kayande said that Nitesh was a child in politics and he is just utilizing his father's name for getting publicity.
    'Pitch Perfect 3' Featurette: The Bellas Are Going on a Global Tour

    'Pitch Perfect 3' Featurette: The Bellas Are Going on a Global Tour

    A real trailer is presumably coming at some point in the future, and Pitch Perfect 3 will be in theaters in December. That's a wrap, kids, with " Pitch Perfect 3 " officially finished production.
  • BJP names Ram Nath Kovind presidential candidate

    BJP names Ram Nath Kovind presidential candidate

    Similarly, another TRS leader Jithender Reddy also backed the NDA's decision and said Kovind is a good choice for the country. The main Opposition parties like Congress , Left and Trinamool Congress had hinted that they might opt for a contest.

    Iran warns missile attack on IS in Syria can be repeated

    It is a derivative of the Fateh-110 missile, and was first test-fired in 2016, and has been featured in Iranian military parades. It is unclear whether the IRGC also coordinated with Iraq prior to launching the missiles into Iraqi airspace.
    Portugal awaits foreign help to fight deadly wildfires

    Portugal awaits foreign help to fight deadly wildfires

    A huge wall of thick smoke and bright red flames towered over the top of trees near houses in the wooded region. He said that "it was not possible to do more than what has been done" in prevention and responding to the fire.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.